SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-026179
Filing Date
2022-09-19
Accepted
2022-09-19 08:45:13
Documents
17
Period of Report
2022-09-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54970
2 ex10-1.htm EX-10.1 35355
3 ex10-2.htm EX-10.2 82257
4 ex99-1.htm EX-99.1 24164
5 ex10-1_001.jpg GRAPHIC 2956
6 ex99-1_001.jpg GRAPHIC 6083
  Complete submission text file 0001493152-22-026179.txt   422057

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE rnxt-20220919.xsd EX-101.SCH 3227
8 XBRL LABEL FILE rnxt-20220919_lab.xml EX-101.LAB 34916
9 XBRL PRESENTATION FILE rnxt-20220919_pre.xml EX-101.PRE 22789
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3880
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 221249631
SIC: 2834 Pharmaceutical Preparations